IMMAGE BIOTHERAPEUTICS CORP.
IMMAGE BIOTHERAPEUTICS CORP. (IMMG): 4 pipeline candidates · ~2 mo cash runway · 3 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
2.3 months
D/E 3.06
Lead: Phase 1/Phase 2
4 candidates
N/A
N/A
A transparent, data-derived signal for IMMAGE BIOTHERAPEUTICS CORP.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$15K
Cash
$54K
Quarterly Burn
$72K
Runway
2.3 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
Frequently asked questions
How many drug candidates are in IMMAGE BIOTHERAPEUTICS CORP.'s pipeline?
IMMAGE BIOTHERAPEUTICS CORP. (IMMG) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is IMMAGE BIOTHERAPEUTICS CORP.'s lead drug candidate?
IMMAGE BIOTHERAPEUTICS CORP.'s most advanced tracked candidate is gb221 (Phase 1/Phase 2) for Spinal Muscular Atrophy Type I.
What is IMMAGE BIOTHERAPEUTICS CORP.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, IMMAGE BIOTHERAPEUTICS CORP. has approximately 2.3 months of cash runway.
What is IMMAGE BIOTHERAPEUTICS CORP.'s market capitalization?
IMMAGE BIOTHERAPEUTICS CORP.'s market capitalization is approximately $15K.
Who is the CEO of IMMAGE BIOTHERAPEUTICS CORP.?
Mr. Zhi Cong Mou is the chief executive officer of IMMAGE BIOTHERAPEUTICS CORP. (IMMG).
Get the full picture on IMMAGE BIOTHERAPEUTICS CORP.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.